BraineHealth AB signs agreement with Isabel Healthcare to power differential diagnostics tools for primary care.
The Swedish company BraineHealth (previously Lugn&Ro Akademin) that is developing automation tools for healthcare using AI methods has signed an agreement with the UK based company Isabel Healthcare to power their differential diagnostics developments in primary care.
BraineHealth´s ambition is to democratize healthcare for everyone everywhere whenever you need it.
Isabel Healthcare is the worldwide frontrunner in the area of differential diagnostics and has for more than 15 years developed a deep learning database of diagnoses that responds to tens of thousands of symptoms.
The agreement covers the use of Isabel Healthcare solution globally.
BraineHealth continues to build their AI-platform for special application in diagnostics and epidemic diseases and is now partly powered inside by Isabel Healthcare.
BraineHealth will shortly release their new suite of applications.
Roger Svensson, CEO BraineHealth AB
tel. +46 (0) 70 799 28 96
About BraineHealth AB
BraineHealth will democratize healthcare globally for everyone everywhere anytime using intelligent healthcare technologies by providing scalable digital solutions based on combined artificial intelligence and robotics.
BraineHealth AB is a Swedish company developing intelligent digital services for consumers and healthcare partners. The company was founded in 2016 by healthcare professionals specialising in primary and elderly care. The company has previously developed a digital platform for online medical advisory services, such as Lugn&Ro Doktorn and an AI-platform for epidemic diseases such as diabetes. BraineHealth is focused on providing patients and the healthcare community scalable solutions based on artificial intelligence, such as for better preventive and self-management care of epidemic diseases. BraineHealth co-operates on testing new products and services with the healthcare provider Lugn&Ro Sverige AB (major owner of BraineHealth).